Author :   Zelinska G.V.

CURRENT IDEAS ABOUT THE CLINICAL AND BIOLOGICAL FEATURES OF RADIOIODINE-REFRACTORY METASTASES OF PAPILLARY THYROID CANCER, THE MECHANISMS DRIVING THEIR DEVELOPMENT, AND PREDICTION METHODS

Authors:Zelinska G.V. №22 3-4 2020 15

CORRELATION OF RADIOIODINE RESISTANCE WITH AGGRESSIVENESS OF PAPILLARY THYROID CARCINOMAS

Authors:Zelinska G.V. №21 4 2019 24

CYTOCHEMICAL AND IMMUNOCYTOCHEMICAL STUDIES Of THYROID PEROXIDASE’ EXPRESSION IN PREOPERATIVE DIAGNOSIS OF THYROID PAPILLARY CARCINOMA AND ITS RADIOIODINE RESISTANT METASTASES

Authors:Zelinska G.V. №21 3 2019 18

CYTOKERATIN 17 AND THYROID PEROXIDASE AS IMMUNOCYTOCHEMICAL MARKERS FOR REOPERATIVE PREDICTION OF RADIOIODINE RESISTANCE AND THE EFFECTIVENESS OF RADIOIODINE THERAPY OF PAPILLARY THYROID CARCINOMA

Authors:Zelinska G.V. №21 1 2019 24

INVESTIGATION OF PROLIFERATIVE ACTIVITY OF CELLS OF RADIOIODINE RESISTANT THYROID PAPILLARY CANCER METASTASES

Authors:Zelinska G.V. №21 2 2019 22

CYTOKERATIN 17 AND THYROID PEROXIDASE AS IMMUNOCYTOCHEMICAL MARKERS FOR REOPERATIVE PREDICTION OF RADIOIODINE RESISTANCE AND THE EFFECTIVENESS OF RADIOIODINE THERAPY OF PAPILLARY THYROID CARCINOMA

Authors:Zelinska G.V. №21 1 2019 38